Echocardiography Test: Clinical Trials

174 trials of Echocardiography Test, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

86 recruiting, 65 active not recruiting, 13 not yet recruiting, 4 terminated. 98 Phase 2, 73 Phase 1, 27 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 298Recruiting 46, Active not recruiting 39, Not yet recruiting 8, Terminated 4, Suspended 1
Phase 173Recruiting 40, Active not recruiting 23, Not yet recruiting 5, Suspended 3, Withdrawn 2
Phase 327Active not recruiting 14, Recruiting 9, Not yet recruiting 2, Completed 1, Terminated 1
Not applicable1Active not recruiting 1

Follow Echocardiography Test: new trials by email Literature Review of Echocardiography Test trials Research Report on Echocardiography Test

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)762027-06-252026-10-22
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)312027-06-012026-10-22
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
Testing the Investigational Medication Combination of Azacitidine, Venetoclax, and Quizartinib Compared to the Usual Treatment of Cytarabine, Daunorubicin, and Quizartinib for Patients With FLT3-ITD Mutant Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration - Acute Myeloid Leukemia
Phase 2Not yet recruitingNational Cancer Institute (NCI)1222027-01-152026-10-07
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy - Acute Myeloid Leukemia
Phase 2Not yet recruitingNational Cancer Institute (NCI)2442027-01-152026-10-20
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
Azacitidine, Bone Marrow Aspiration and Biopsy, Cytarabine - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2Not yet recruitingNational Cancer Institute (NCI)1842027-01-042026-10-01
Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Asciminib, Biospecimen Collection, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1RecruitingCity of Hope Medical Center302026-12-172026-10-19
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1Not yet recruitingCity of Hope Medical Center192026-12-142026-05-13
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group702026-12-112026-09-30
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Anti-GPC3-CAR Autologous T Lymphocytes, Biospecimen Collection, Computed Tomography - Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
Phase 1SuspendedRoswell Park Cancer Institute242026-11-152026-09-15
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia
Phase 2RecruitingCity of Hope Medical Center352026-11-052026-10-08
IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer
FH-STEAP1 IL-18 CAR T cells, Antiandrogen Therapy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 1Not yet recruitingFred Hutchinson Cancer Center202026-10-312026-09-04
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia
Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia
Phase 1RecruitingFred Hutchinson Cancer Center92026-10-152026-09-17
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingSWOG Cancer Research Network902026-10-142026-10-13
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1Not yet recruitingNational Cancer Institute (NCI)152026-10-092026-08-13
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Biopsy Procedure, Biospecimen Collection, Echocardiography Test - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)362026-10-062026-10-16
Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia
Phase 2RecruitingUma Borate702026-10-012026-08-27

Showing 20 of 174. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (33)  ·  Neoplasm Metastasis (15)  ·  Myelodysplastic Syndromes (14)  ·  Lung Neoplasms (13)  ·  Carcinoma, Non-Small-Cell Lung (11)  ·  Leukemia, Biphenotypic, Acute (10)  ·  Lymphoma (10)  ·  Burkitt Lymphoma (9)  ·  Multiple Myeloma (8)  ·  Fallopian Tube Neoplasms (7)  ·  Melanoma (7)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (7)  ·  Endometrial Neoplasms (6)  ·  Lymphoma, Large B-Cell, Diffuse (6)  ·  Ovarian Neoplasms (6)

Sponsors

National Cancer Institute (NCI) (104)  ·  Fred Hutchinson Cancer Center (16)  ·  Children's Oncology Group (12)  ·  City of Hope Medical Center (11)  ·  Mayo Clinic (6)  ·  OHSU Knight Cancer Institute (3)  ·  Ohio State University Comprehensive Cancer Center (3)  ·  Roswell Park Cancer Institute (3)  ·  SWOG Cancer Research Network (3)  ·  University of Washington (3)  ·  Uma Borate (2)  ·  AIDS Malignancy Consortium (1)  ·  Asrar Alahmadi (1)  ·  Emory University (1)  ·  Jennifer Saultz (1)

Countries

United States (165)  ·  Canada (25)  ·  Puerto Rico (24)  ·  Australia (10)  ·  Guam (4)  ·  New Zealand (4)  ·  Israel (2)  ·  South Korea (2)  ·  Japan (1)  ·  Switzerland (1)

Top investigators

Joyce F Liu (4)  ·  A P Chen (3)  ·  Ibrahim Aldoss (3)  ·  Amandeep Salhotra (2)  ·  Amer M Zeidan (2)  ·  Andrea B Apolo (2)  ·  Curtis A Lachowiez (2)  ·  Funda Meric-Bernstam (2)  ·  Jibran Ahmed (2)  ·  Rosa Nadal Rios, MD, PhD (2)  ·  Timothy A Yap (2)  ·  Aarti Bhatia (1)  ·  Adam J Esbenshade (1)  ·  Alain P Algazi (1)  ·  Alan L Ho (1)

Results publications

PMID 35031545, PMID 37185961, PMID 41911908, PMID 23810467, PMID 25218906, PMID 26586415, PMID 27811504, PMID 29211618, PMID 29784747, PMID 31449468, PMID 31969335, PMID 32463741, PMID 32597469, PMID 32915679, PMID 33020646, PMID 33048619, PMID 33362722, PMID 33394722, PMID 33395032, PMID 33878954, PMID 33882143, PMID 34028986, PMID 34380663, PMID 34416167, PMID 34686472, PMID 34716198, PMID 35133871, PMID 35138919, PMID 35170751, PMID 35175355, PMID 35290101, PMID 35297944, PMID 35613998, PMID 36166727, PMID 36322825, PMID 36351402, PMID 36521030, PMID 36898933, PMID 36902217, PMID 37053535, PMID 37322121, PMID 37597578, PMID 37934000, PMID 38127487, PMID 38243705, PMID 38358334, PMID 38433347, PMID 38591867, PMID 38954785, PMID 39067873

NIH funding

U10CA180820 (23), U10CA180886 (17), P30CA033572 (11), U10CA180821 (11), U10CA180888 (10), U10CA180868 (9), UM1CA186689 (9), UM1CA186709 (9), UM1CA186688 (7), UM1CA186717 (6), UM1CA228823 (6), UM1CA186644 (5), UM1CA186704 (5), ZIABC011078 (5), UM1CA186691 (4)